The Department of Transportation has tentatively redistributed the landing rights in Mexico City and New York that it is requiring Delta and Aeromexico to surrender under the terms of the antitrust immunity approval the DOT awarded in December.
Alaska has been tentatively approved to operate four daily flights beginning this summer to Mexico City — two from Los Angeles, one from San Francisco and one from San Diego.
Southwest’s request for the right to fly twice daily beginning this summer between Mexico City and Houston Hobby was tentatively approved, and the DOT looked favorably on Southwest’s request for slots opening in summer 2018 to service Mexico City daily out of Fort Lauderdale and Los Angeles.
JetBlue tentatively won the right to fly twice daily to Mexico City beginning this summer from Fort Lauderdale and Orlando and twice daily beginning next summer from Los Angeles.
The DOT was less generous to Mexican carriers Volaris and especially VivaAerobus in their requests for slots in Mexico City and New York, where the Delta/Aeromexico partnership had to surrender four daily landing rights. Volaris lost out in its landing right request for flights from JFK to Cancun, but was tentatively approved for nine other daily or semi-daily routes between the US and Mexico City.
Full Content: CH Aviation
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas